drugset / Trial / NCT00636935

Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP)

NCT00636935 ↗

Phase 4 Withdrawn George Washington University
RandomizedParallel-groupOpen-labelTreatment

Summary

To explore the effects of corticosteroid therapy on pulmonary fibrosis and potentially pneumothorax in patients with mild PCP (pO2 \>70mmHg) combined with the standard of care treatment of antibiotic therapy.

Timeline

Start
2008-02
Primary completion
2013-08
Completion
2013-08

Outcome

Outcome not reported

Stopped: “No patient completed protocol”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisone Other / unclassified 40 mg Oral
Background Atovaquone Small molecule — —
Background Bactrim Unknown — —
Background Clindamycin Unknown — —
Background Dapsone Small molecule — —
Background Pentamidine Unknown — —
Background Primaquine Small molecule — —
Background Trimethoprim Small molecule — —

Indications